Somerset Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,771
Closed -$1.57M 75
2017
Q3
$1.57M Hold
10,771
1.43% 18
2017
Q2
$1.4M Hold
10,771
1.3% 20
2017
Q1
$1.34M Hold
10,771
1.27% 20
2016
Q4
$1.25M Hold
10,771
1.23% 21
2016
Q3
$1.13M Hold
10,771
1.16% 22
2016
Q2
$1.06M Hold
10,771
1.11% 26
2016
Q1
$1.08M Hold
10,771
1.17% 23
2015
Q4
$1.29M Sell
10,771
-1,545
-13% -$179K 1.37% 19
2015
Q3
$1.33M Sell
12,316
-36
-0.3% -$4.47K 1.45% 19
2015
Q2
$1.43M Hold
12,352
1.36% 23
2015
Q1
$1.42M Sell
12,352
-325
-3% -$38.8K 1.27% 23
2014
Q4
$1.42M Buy
+12,677
New +$1.34M 1.26% 23

Other funds holding CELG

Somerset Group's CELG Position: Q4 2017 in Review

Somerset Group sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 10,771 shares — an estimated $1.57M sold.

Somerset Group first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $1.57M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Somerset Group reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Somerset Group sold 10,771 Celgene Corp shares in Q4 2017, an estimated $1.57M.
  • Somerset Group first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
  • Somerset Group's Celgene Corp position peaked at $1.57M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Somerset Group's 13F filing for Q4 2017, filed 12 Feb 2018.